News & publications

News from Aminex.

Discover the research, milestones, and stories shaping the future of Aminex.

Aminex scientific research visualization
  1. June 2026
    Coverage

    Aminex: A New Direction in Oncology Emerges from Years of Polyamine Research

    Read More
  2. March 2026
    Press release

    Aminex Therapeutics Receives Second FDA Orphan Drug Designation for AMXT 1501 for Malignant Glioma

    Read More
  3. February 2026
    Press release

    Aminex Therapeutics Announces Multiple Sites Activated for Phase 1b/2 Clinical Trial

    Read More
  4. November 2025
    Coverage

    CTI and Aminex Therapeutics Announce Partnership to Advance Clinical Development

    Read More
  5. October 2025
    Coverage

    Beat Childhood Cancer Consortium and Aminex Announce Pediatric Clinical Trial

    Read More
  6. October 2025
    Press release

    Aminex Therapeutics Announces FDA Orphan Drug Designation for Neuroblastoma

    Read More
  7. September 2025
    Press release

    Phase I Results Published in ESMO Open

    Read More
  8. March 2025
    Publication

    Molecular Oncology: The polyamine transporter ATP13A3 mediates DFMO-induced uptake

    Read More
  9. February 2025
    Publication

    International Journal of Cancer: Polyamine depletion limits progression of acute leukaemia

    Read More
  10. September 2024
    Press release

    Aminex Announces Appointment of David Meek as Executive Chairman

    Read More
  11. April 2023
    Announcement

    Aminex completes Phase 1a portion of clinical trial evaluating AMXT-1501 and DFMO

  12. November 2022
    Announcement

    Aminex Enrolls First Patient in Phase 1B Trial of AMXT-1501 and DFMO

  13. August 2022
    Announcement

    Aminex Therapeutics Completes Enrollment in Phase 1A portion of Clinical Trial Evaluating AMXT 1501 and DFMO

  14. February 2021
    Press release

    Sydney Researchers Identify Potential New Drug Treatment for Fatal Childhood Cancer

    Read More
  15. January 2019
    Press release

    International Research Team Reports Potential Way to Treat Neuroblastoma

    Read More
  16. June 2018
    Press release

    Aminex Therapeutics Initiates First Clinical Trial of AMXT 1501 + DFMO

    Read More
  17. November 2015
    Press release

    Aminex Therapeutics, Inc. Closes $4M Series A Financing

    Read More

Historical PDFs and press releases retain their original wording. Several older items include statements superseded by the current website brief.